Breast Diseases
Conditions
Brief summary
Patients were randomized into two groups, ESP and control. Single-shot ultrasound (US)-guided ESP block with 20 ml 0.25% bupivacaine at the T4 vertebral level was performed preoperatively to all patients in the ESP group. The control group received no intervention. Patients in both groups were provided with intravenous patient-controlled analgesia device containing morphine for postoperative analgesia.
Interventions
PROCEDUREErector Spinae Plane Block
Single-shot ultrasound (US)-guided ESP block with 20 ml 0.25% bupivacaine ( Marcaine ) at the T4 vertebral level will be performed.
PROCEDUREStandart therapy
Postoperative 0.5 mg/kg morphine and 1 gr paracetamol will be admistered intravenously in the operation theatre and intravenous patient controlled analgesia (PCA) will be performed in the plastic surgery ward postoperatively
Sponsors
Gözde Gamze Uzun
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Intervention model description
Patients were randomized into two groups, ESPB and control.
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
1. 18-65 age 2. Patients who scheduled for bilateral reduction mammoplasty 3. ASA Class I-II
Exclusion criteria
1\. Coagulopaty
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Total opioid consumption | Postoperative total opioid consumption in miligrams will be recorded at hour 24 | Patients in both groups will receive opioid in postoperative period. Total opioid consumption in miligrams will be compared |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Intraoperative opioid consumption | At the end of the operation | The amount of remifentanyl administered to patients via intravenous infusion during the operation in micrograms, will be recorded. |
Countries
Turkey (Türkiye)
Outcome results
None listed